These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 26271127)

  • 1. Meta-Analysis Comparing Rosuvastatin and Atorvastatin in Reducing Concentration of C-Reactive Protein in Patients With Hyperlipidemia.
    Ma Q; Zhou Y; Zhai G; Gao F; Zhang L; Wang J; Yang Q; Cheng W
    Angiology; 2016 Jul; 67(6):526-35. PubMed ID: 26271127
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparision of effects of rosuvastatin versus atorvastatin treatment on plasma levels of asymmetric dimethylarginine in patients with hyperlipidemia having coronary artery disease.
    Kurtoglu E; Balta S; Sincer I; Altas Y; Atas H; Yilmaz M; Korkmaz H; Erdem K; Akturk E; Demirkol S; Can C
    Angiology; 2014 Oct; 65(9):788-93. PubMed ID: 24163120
    [TBL] [Abstract][Full Text] [Related]  

  • 3. To what extent do high-intensity statins reduce low-density lipoprotein cholesterol in each of the four statin benefit groups identified by the 2013 American College of Cardiology/American Heart Association guidelines? A VOYAGER meta-analysis.
    Karlson BW; Palmer MK; Nicholls SJ; Lundman P; Barter PJ
    Atherosclerosis; 2015 Aug; 241(2):450-4. PubMed ID: 26074319
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of treatment with atorvastatin versus rosuvastatin on endothelial dysfunction in patients with hyperlipidaemia.
    Demir V; Doğru MT; Ede H; Yilmaz S; Alp C; Celik Y; Yildirim N
    Cardiovasc J Afr; 2018 May/Jun 23; 29(3):162-166. PubMed ID: 29528361
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A meta-analysis of randomized head-to-head trials for effects of rosuvastatin versus atorvastatin on apolipoprotein profiles.
    Takagi H; Umemoto T;
    Am J Cardiol; 2014 Jan; 113(2):292-301. PubMed ID: 24230979
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparing effectiveness of high-dose Atorvastatin and Rosuvastatin among patients undergone Percutaneous Coronary Interventions: A non-concurrent cohort study in India.
    Roy D; Mahapatra T; Manna K; Kar A; Rana MS; Roy A; Bose PK; Banerjee B; Paul S; Chakraborty S
    PLoS One; 2020; 15(5):e0233230. PubMed ID: 32428019
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Cost-effectiveness of rosuvastatin versus simvastatin, atorvastatin and pitavastatin in patients with high and very high cardiovascular risk in Spain].
    Cosin Sales J; Fuentes Jiménez FJ; Mantilla Morató T; Ruiz E; Becerra V; Aceituno S; Ferrario MG; Lizán L; Gracia A
    Clin Investig Arterioscler; 2015; 27(5):228-38. PubMed ID: 25640158
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of atorvastatin versus rosuvastatin on inflammatory biomarkers and LV function in type 2 diabetic patients with dyslipidemia.
    Werida R; Khairat I; Khedr NF
    Biomed Pharmacother; 2021 Mar; 135():111179. PubMed ID: 33401219
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative effects of high-dose atorvastatin versus moderate-dose rosuvastatin on lipid parameters, oxidized-LDL and inflammatory markers in ST elevation myocardial infarction.
    Aydin MU; Aygul N; Altunkeser BB; Unlu A; Taner A
    Atherosclerosis; 2015 Apr; 239(2):439-43. PubMed ID: 25697576
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Variability of low-density lipoprotein cholesterol response with different doses of atorvastatin, rosuvastatin, and simvastatin: results from VOYAGER.
    Karlson BW; Wiklund O; Palmer MK; Nicholls SJ; Lundman P; Barter PJ
    Eur Heart J Cardiovasc Pharmacother; 2016 Oct; 2(4):212-7. PubMed ID: 27533947
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A VOYAGER Meta-Analysis of the Impact of Statin Therapy on Low-Density Lipoprotein Cholesterol and Triglyceride Levels in Patients With Hypertriglyceridemia.
    Karlson BW; Palmer MK; Nicholls SJ; Lundman P; Barter PJ
    Am J Cardiol; 2016 May; 117(9):1444-8. PubMed ID: 26969416
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety of High-Intensity Statins in the Veteran Population: Atorvastatin 40 to 80 mg Compared With Rosuvastatin 20 to 40 mg.
    Stein B; Ward T; Hale G; Lyver E
    Ann Pharmacother; 2020 May; 54(5):405-413. PubMed ID: 31718234
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect of atorvastatin on C-reactive protein and benefits for cardiovascular disease in patients with type 2 diabetes: analyses from the Collaborative Atorvastatin Diabetes Trial.
    Soedamah-Muthu SS; Livingstone SJ; Charlton-Menys V; Betteridge DJ; Hitman GA; Neil HA; Bao W; DeMicco DA; Preston GM; Fuller JH; Stehouwer CD; Schalkwijk CG; Durrington PN; Colhoun HM;
    Diabetologia; 2015 Jul; 58(7):1494-502. PubMed ID: 25899452
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Meta-analysis comparing the effects of rosuvastatin versus atorvastatin on regression of coronary atherosclerotic plaques.
    Qian C; Wei B; Ding J; Wu H; Cai X; Li B; Wang Y
    Am J Cardiol; 2015 Nov; 116(10):1521-6. PubMed ID: 26385518
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Rapid (Differential) Effect of Rosuvastatin and Atorvastatin on High-Sensitivity Cardiac Troponin-I in Subjects With Stable Cardiovascular Disease.
    Bodde MC; Welsh P; Bergheanu SC; Lijfering WM; Mertens B; Liem AH; van der Laarse A; Sattar N; Jukema JW
    Clin Pharmacol Ther; 2018 Aug; 104(2):311-316. PubMed ID: 29672821
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Doses of rosuvastatin, atorvastatin and simvastatin that induce equal reductions in LDL-C and non-HDL-C: Results from the VOYAGER meta-analysis.
    Karlson BW; Palmer MK; Nicholls SJ; Lundman P; Barter PJ
    Eur J Prev Cardiol; 2016 May; 23(7):744-7. PubMed ID: 26246463
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of atorvastatin or rosuvastatin co-administration on platelet reactivity in patients treated with dual antiplatelet therapy.
    Verdoia M; Nardin M; Sartori C; Pergolini P; Rolla R; Barbieri L; Marino P; Bellomo G; Suryapranata H; De Luca G;
    Atherosclerosis; 2015 Dec; 243(2):389-94. PubMed ID: 26520891
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of statin therapy on plasma adiponectin concentrations: A systematic review and meta-analysis of 43 randomized controlled trial arms.
    Chruściel P; Sahebkar A; Rembek-Wieliczko M; Serban MC; Ursoniu S; Mikhailidis DP; Jones SR; Mosteoru S; Blaha MJ; Martin SS; Rysz J; Toth PP; Lip GY; Pencina MJ; Ray KK; Banach M;
    Atherosclerosis; 2016 Oct; 253():194-208. PubMed ID: 27498397
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship between inflammation and benefits of early high-dose rosuvastatin on contrast-induced nephropathy in patients with acute coronary syndrome: the pathophysiological link in the PRATO-ACS study (Protective Effect of Rosuvastatin and Antiplatelet Therapy on Contrast-Induced Nephropathy and Myocardial Damage in Patients With Acute Coronary Syndrome Undergoing Coronary Intervention).
    Toso A; Leoncini M; Maioli M; Tropeano F; Di Vincenzo E; Villani S; Bellandi F
    JACC Cardiovasc Interv; 2014 Dec; 7(12):1421-9. PubMed ID: 25523533
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Comparison of Statin Therapies in Hypercholesterolemia in Women: A Subgroup Analysis of the STELLAR Study.
    Welty FK; Lewis SJ; Friday KE; Cain VA; Anzalone DA
    J Womens Health (Larchmt); 2016 Jan; 25(1):50-6. PubMed ID: 26539650
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.